Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R 16341
2. R-16341
3. R16341
4. Semap
1. 26864-56-2
2. Semap
3. 1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol
4. Penfluridolum
5. Mcn-jr-16,341
6. Tlp-607
7. R-16341
8. 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
9. Micefal
10. 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol
11. R 16341
12. Nsc-759179
13. Chembl47050
14. 4-piperidinol, 1-(4,4-bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)-
15. 25tlu22q8h
16. Mcn-jr-16341
17. R 16,341
18. 4-piperidinol, 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-
19. Ncgc00165865-01
20. Dsstox_cid_28947
21. Dsstox_rid_83212
22. Dsstox_gsid_49021
23. Penfluridolum [inn-latin]
24. Cas-26864-56-2
25. Einecs 248-074-5
26. Brn 1558826
27. Unii-25tlu22q8h
28. Longoperidol
29. Penfluridol [usan:inn:ban]
30. 1-(4,4-bis(p-fluorophenyl)butyl)-4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-piperidinol
31. 1-[4,4-bis(p-fluorophenyl)butyl]-4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-piperidinol
32. Mfcd00866714
33. Semap (tn)
34. Penfluridol [mi]
35. Penfluridol [inn]
36. Penfluridol [jan]
37. Penfluridol (usan/inn)
38. Penfluridol [usan]
39. Penfluridol [mart.]
40. Schembl93939
41. Penfluridol [who-dd]
42. 1-(4,4-bis(p-fluorophenyl)butyl)-4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-4-piperidinol
43. 5-21-02-00409 (beilstein Handbook Reference)
44. Mls004774011
45. Dtxsid5049021
46. Chebi:92278
47. Hms3264l13
48. Hms3652g22
49. Pharmakon1600-01505691
50. Act03196
51. Bcp03695
52. Hy-b1077
53. Zinc4217252
54. Tox21_113546
55. Bdbm50026066
56. Nsc759179
57. Pdsp1_000470
58. Pdsp2_000468
59. Akos005065828
60. Tox21_113546_1
61. Bcp9000014
62. Ccg-269878
63. Cs-4633
64. Db13791
65. Ks-5104
66. Nsc 759179
67. Penfluridol, >=97% (hplc), Powder
68. 4-piperidinol,1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-
69. Ncgc00165865-02
70. Ncgc00165865-03
71. 4-piperidinol, 1-(4,4-bis(p-fluorophenyl)butyl)-4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-
72. 4-piperidinol, 4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-1-(4,4-bis(p-fluorophenyl)butyl)-
73. Ac-15413
74. Smr003500704
75. Bcp0726000159
76. Sbi-0206898.p001
77. Db-017683
78. Ft-0645031
79. P2076
80. S4151
81. Sw219540-1
82. D02630
83. Ab01566919_01
84. 864p562
85. A818637
86. L001145
87. Sr-05000001779
88. Q2149707
89. Sr-05000001779-1
90. W-107147
91. Brd-k15409150-001-01-7
92. 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloranyl-3-(trifluoromethyl)phenyl]piperidin-4-ol
93. 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-piperidin-4-ol
94. 1-[4,4-bis-(4-fluoro-phenyl)-butyl]-4-(4-chloro-3-trifluoromethyl-phenyl)-piperidin-4-ol
95. 1-[4,4-bis(p-flurophenyl)butyl]-4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-piperidinol
96. 4-piperidinol, 4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-1-(4,4-bis(p-fluorophenyl)butyl)-
97. Penfluridol1-[4,4-bis-(4-fluoro-phenyl)-butyl]-4-(4-chloro-3-trifluoromethyl-phenyl)-piperidin-4-ol
Molecular Weight | 524.0 g/mol |
---|---|
Molecular Formula | C28H27ClF5NO |
XLogP3 | 7.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 523.1701330 g/mol |
Monoisotopic Mass | 523.1701330 g/mol |
Topological Polar Surface Area | 23.5 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 647 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
N05AG03
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AG - Diphenylbutylpiperidine derivatives
N05AG03 - Penfluridol
ABOUT THIS PAGE
A Penfluridol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Penfluridol, including repackagers and relabelers. The FDA regulates Penfluridol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Penfluridol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Penfluridol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Penfluridol supplier is an individual or a company that provides Penfluridol active pharmaceutical ingredient (API) or Penfluridol finished formulations upon request. The Penfluridol suppliers may include Penfluridol API manufacturers, exporters, distributors and traders.
click here to find a list of Penfluridol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Penfluridol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Penfluridol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Penfluridol GMP manufacturer or Penfluridol GMP API supplier for your needs.
A Penfluridol CoA (Certificate of Analysis) is a formal document that attests to Penfluridol's compliance with Penfluridol specifications and serves as a tool for batch-level quality control.
Penfluridol CoA mostly includes findings from lab analyses of a specific batch. For each Penfluridol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Penfluridol may be tested according to a variety of international standards, such as European Pharmacopoeia (Penfluridol EP), Penfluridol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Penfluridol USP).
LOOKING FOR A SUPPLIER?